CAS 1220887-84-2
:(1R,4R,5R)-4-[4-(1,1-Dimetileptil)-2,6-dimetossifenil]-6,6-dimetilbiciclo[3.1.1]ept-2-ene-2-metanolo
- Bicyclo[3.1.1]hept-2-ene-2-methanol, 4-[4-(1,1-dimethylheptyl)-2,6-dimethoxyphenyl]-6,6-dimethyl-, (1R,4R,5R)-
- (1R,4R,5R)-4-[4-(1,1-Dimethylheptyl)-2,6-dimethoxyphenyl]-6,6-dimethylbicyclo[3.1.1]hept-2-ene-2-methanol
- HU 433
HU 433
CAS:Prodotto controllatoHU 433 is an analog that has shown potent anticancer properties. It is a kinase inhibitor that targets specific proteins involved in cancer cell growth and survival. HU 433 induces apoptosis, or programmed cell death, in human cancer cells. This compound has been tested extensively in Chinese hamster ovary cells and has shown to be effective against a variety of tumor types. HU 433 inhibits the activity of kinases involved in protein synthesis and cellular signaling pathways, leading to the suppression of tumor growth. This compound has also been formulated with chitosan for improved delivery and bioavailability. HU 433 may hold promise as a potential cancer therapy due to its ability to selectively target cancer cells while sparing healthy tissue.
Formula:C27H42O3Purezza:Min. 95%Colore e forma:PowderPeso molecolare:414.6 g/molHU 433
CAS:HU 433, a synthetic cannabinoid, acts as a CB2 receptor agonist and is an enantiomer of HU 308. It provides anti-inflammatory and neuroprotective effects by binding to the CB2 receptor, primarily found on immune cells, thereby modulating immune responses and inflammation. Additionally, HU 433 influences microglial signaling pathways, particularly LPS and IFNγ-mediated routes, affecting the phosphorylation of MAPKs, including ERK1/2, JNK, p38, and Akt. This compound is valuable in researching neuroinflammation and retinal diseases.
Formula:C27H42O3Colore e forma:SolidPeso molecolare:414.62


